For centuries, there have been two fundamental pillars of medicine: surgery and drugs.
Now… a third pillar: cellular medicine has the potential to awaken the body’s innate healing intelligence. By using the body’s natural ability to repair and regenerate itself, we aim to create less invasive, more effective therapies for a variety of conditions thus using the body’s innate cellular healing intelligence.
Improving patient outcomes and their healing processes through advancements in cellular treatments and technologies.
Utilising research and technology to become the first approved cellular treatment for osteoarthritis of the knee.
GID BIO, Inc. is a global leader in cellular therapy, offering a tissue processing platform that enables cell-based treatments for a broad range of therapies. Our team of seasoned executives, adipose tissue scientists, and surgeons works together to discover a reliable, cost-effective solution that utilizes patients’ own cells as a treatment option.
A team is more than a collection of people.
Chief Financial Officer & Treasurer, CPA, CGMA
Through intensive research and development, we are moving rapidly towards our goal of a simple, reproducible, predictable, cost-effective solution to the treatment gap between drug and invasive surgical treatments.
